Halsey Associates’s Allergan plc AGN.PRA Stock Holding History

Halsey Associates’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,416	Closed	-$3.76M	–	108
2017 Q4	$3.76M	Sell	6,416 -5,149	-45%	-$3.32M	0.64%	40
2017 Q3	$8.53M	Buy	11,565 +18	+0.2%	+$14.9K	1.68%	25
2017 Q2	$10M	Sell	11,547 -204	-2%	-$171K	2.06%	21
2017 Q1	$9.97M	Buy	11,751 +381	+3%	+$316K	2.11%	22
2016 Q4	$8.67M	Buy	11,370 +593	+6%	+$448K	1.93%	25
2016 Q3	$8.85M	Buy	+10,777	New	+$9.32M	1.92%	24

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Halsey Associates's AGN.PRA Position: Q1 2018 in Review

Halsey Associates sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 6,416 shares — an estimated $3.76M sold.

Halsey Associates first reported a position in AGN.PRA in Q3 2016 and held it in 6 quarters. The position peaked at $10M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Halsey Associates reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Halsey Associates sold 6,416 Allergan plc shares in Q1 2018, an estimated $3.76M.
Halsey Associates first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
Halsey Associates's Allergan plc position peaked at $10M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Halsey Associates's 13F filing for Q1 2018, filed 14 May 2018.